Across the world, more than 1.5 billion people suffer from chronic liver disease. The U.S. Centers for Disease Control and ...

Microscopy image showing activated hepatic stellate cells (HSCs), indicated by red staining (left image). Inhibition of CYB1B1 reduces HSC activation (right image), which leads to reduced liver ...

Once almost exclusively seen in older adults, fatty liver disease, which can be fatal if untreated, is now one of the world’s ...

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel treatment approach for this common and serious condition ...

Liver fibrosis, a progressive scarring of the liver tissue, represents a major global health burden with limited treatment ...

Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...

A new study suggests a combination of cardiovascular drugs, pemafibrate and telmisartan, may reverse fatty liver disease by ...

Congenital hepatic fibrosis is a type of liver disease that is present from birth. It typically affects the function of the bile ducts and the veins that carry blood from the digestive tract to the ...

Discover a study showing how COVID-19 affects people with chronic liver disease, highlighting the importance of vaccination.

The liver, located in the upper right side of the abdomen, is the body’s largest organ and one of the most important. The liver performs hundreds of vital functions, including converting nutrients ...